SG

Sapna Gupta

Active Director Director DIN 06869833
DIN 06869833 First appointment Jul 2014 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Sapna Gupta

Data last updated:

Sapna Gupta is a Director at Sanios Pharmaceuticals Private Limited (since 2014). The company operates in Service. Sanios Pharmaceuticals Private Limited reported revenue of ₹1.54 Cr (FY 2025).

DIN 06869833
Primary Designation Director
Industry Service
First Appointment 07 Jul 2014
Oldest Company Age 12 yrs
Largest company Sanios Pharmaceuticals Private Limited · ₹1.54 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20142014₹1.54 Cr (FY 2025)Active

Board colleagues of Sapna Gupta

NameDINCompanyDesignation
Rajnish Kumar Gupta06869861Sanios Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sanios Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sapna Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sapna Gupta

Sapna Gupta currently holds 1 directorship: Sanios Pharmaceuticals Private Limited (Director, since 07 Jul 2014, revenue ₹1.54 Cr (FY 2025)).

Sapna Gupta was first appointed on 07 Jul 2014 as Director at Sanios Pharmaceuticals Private Limited.

The current boards of Sapna Gupta's companies include Rajnish Kumar Gupta (Sanios Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available